the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes. .
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the http://lm360.us/Monterrano-daughter-of-Bera-from-Behrensdorf?Saisason=294 email .